Author: Anna Sundin

Survey on Research Infrastructures and AMR

The JPIAMR is conducting a short survey on knowledge about and use of Research Infrastructures (RI’s) within the field of antimicrobial resistance. The survey is open to all scientists and other interested parties who are involved in this field.

With this short survey, the JPIAMR would like to identify the needs and wishes of the AMR scientific community regarding the collaboration with and use of RIs. Moreover, we would like to know whether there is an opportunity for the JPIAMR to help bring people working in RIs and AMR (closer) together, and if so, in what way(s).

The survey can be accessed at:

https://www.surveymonkey.com/s/JPIAMR-RIs

The survey can be completed using all current web browsers, but is best viewed using Mozilla Firefox.
The deadline for completion of the survey is March 29, 2015.

Questions regarding the survey should be directed to the JPIAMR-team at jpiamr@zonmw.nl.

 

 

A prize of €1 million will be awarded to the person or team that develops a rapid test to tell whether a patient needs to be treated with antibiotics or not, the European Commission announced today. The aim of the Horizon Prize for better use of antibiotics is to stop many patients from taking antibiotics needlessly, which is one of the main reasons for the rise of antimicrobial resistance. European Commissioner for Research, Science and Innovation Carlos Moedas said: “Growing resistance to antibiotics is one of the biggest challenges to public health today. We need to find new ways to prevent people from dying from infections that have been treatable for decades, until resistance rendered our drugs ineffective. We need to bring new classes of antibiotics to market and we need to take preventative measures to stop antibiotics being over-prescribed and over-used. Under Horizon 2020 we are continuing to help save lives and reduce the €1.5 billion in healthcare expenses and productivity losses the EU incurs each year from drug-resistant infections.” For more information read:

The full news alert

Website

Infographic

JPIAMR welcome the AMR Review today’s report “Tackling a global health crisis: Initial steps” and the focus on constructive actions to tackle AMR. As the primary focus of the Joint Programming Initiative on Antimicrobial Resistance (JPIAMR) is to promote research on AMR we strongly support the idea of setting up a global fund for research and innovation to support early-stage science. Click here to view the article.

The White House proposed a $1.2 billion investment in new drug development, antibiotic stewardship and surveillance programs and evaluation of antibiotic use in agriculture as part of the 2016 federal budget.

Data on antimicrobial consumption and use  and occurrence of antimicrobial resistance in humans and animals is presented in a report published jointly by the European Centre for Disease Prevention and Control (ECDC), the European Food Safety Authority (EFSA) and the European Medicines Agency (EMA). The analysis combines data from  five European monitoring networks that gather information from the European Union (EU) Member States, Iceland, Norway and Switzerland. Click here to view the report.

 

In order to promote coordination, alignment of agendas, coverage of research gaps and avoidance of duplications, the JPI AMR needs to collect and analyse information of the research done on the field under national programmes. The same is valid regarding the evaluation of JPI AMR own activities and the assessment of its impact. To this aim, the completion of a database of AMR funded projects is expected as part of the proposed framework for the Evaluation of the JPI. This workshop will be focused on understanding the National Information Systems (databases) of the AMR European funding organisations. In order to complete the database of projects foreseen on the JPI AMR evaluation framework. More information and the agenda can be found here.

 

The ENABLE project seeks to build a substantial pipeline of innovative programmes and has initially fuelled the engine with a portfolio of programmes brought together at the original call. The project will be seeking external Gram-negative programmes to join the project and enter the pipeline for:

• Hit to Lead programmes
• Lead to Candidate programmes